AI assistant
DARLING INGREDIENTS INC. — Director's Dealing 2021
Mar 8, 2021
31039_dirs_2021-03-08_e8b4aa18-220f-4fb1-b767-ff43bbf00b11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DARLING INGREDIENTS INC. (DAR)
CIK: 0000916540
Period of Report: 2021-03-04
Reporting Person: Vervoort Jos (EVP - Rousselot)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-04 | Common Stock | S | 14000 | $68.13 | Disposed | 49109 | Direct |
| 2021-03-04 | Common Stock | M | 9410 | $18.82 | Acquired | 58519 | Direct |
| 2021-03-04 | Common Stock | M | 8274 | $21 | Acquired | 66793 | Direct |
| 2021-03-04 | Common Stock | M | 7583 | $28.89 | Acquired | 74376 | Direct |
| 2021-03-04 | Common Stock | F | 16858 | $66.16 | Disposed | 57518 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-04 | Options (right to buy) | $18.82 | M | 9410 | Disposed | 2028-01-29 | Common Stock (9410) | Direct |
| 2021-03-04 | Options (right to buy) | $21 | M | 8274 | Disposed | 2029-01-25 | Common Stock (8274) | Direct |
| 2021-03-04 | Options (right to buy) | $28.89 | M | 7583 | Disposed | 2030-01-06 | Common Stock (7583) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $68.00 to $68.35? the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
F2: Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 9,409 shares became exercisable on 1/29/2019 and 1/29/2020 and 9,410 shares became exercisable on 1/29/2021.
F3: Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 8,274 shares became exercisable on 1/25/2020 and 1/25/2021 and 8,274 will become exercisable 1/25/2022.
F4: Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 7,583 shares became exercisable on 1/6/2021 and 7,582 shares will become exercisable on 1/6/2022 and 1/25/2023.